SlideShare a Scribd company logo
1 of 20
Vaccine Logistics
By
Shyam S. Sonecha
Objectives :-
1. Vaccine Left Out
2. Vaccine Drop Out Rate
3. Efficacy of Vaccine
4. Vaccine and Materials (syringes)
- Usage & Wastage rate
- Wastage Factor
- Calculation (Beneficiaries, Vaccines & Syringes)
Vaccine Left Out
A child or a woman, who has not taken any
vaccine, even for which he/she is eligible, is
known as Left Out Vaccine.
Vaccine Dropout Rate
Dropout is defined as a child or a woman
who failed to return for subsequent doses of
immunizations for which he/she is eligible.
Drop out rate =
Highest covered antigen - Lowest covered antigen x100
Highest covered antigen
Over all drop out rate =
Coverage with BCG - Coverage with measles x 100
Coverage with BCG
Drop out rate for a single antigen(e.g. OPV) =
Coverage with OPV1 - Coverage with OPV3 x 100
Coverage with OPV1
Example 1: Calculate Pentavalent dropout rate and full
immunization dropout rate for a PHC from the given data for the
year 2015. Population of PHC was 30000. BCG coverage was 560.
Pentavalent 1 & OPV 1 coverage was 580. Pentavalent 3 & OPV 3
coverage was 510. Measles coverage was 500.
Example 2: Calculate Pentavalent, OPV dropout rate and full
immunization dropout rate for a PHC from the given data for the
year 2019. Population of PHC was 21000. BCG coverage was 650.
Pentavalent 1 & OPV 1 coverage was 590 and 600. Pentavalent 3 &
OPV 3 coverage was 560 and 590. Measles coverage was 550.
Answers
1 Overall dropout = 10.71%
Pentavalent dropout = 12.07% = OPV dropout
2 Overall dropout = 15.38%
Pentavalent dropout = 5.1%
OPV dropout = 1.67%
Definition :
It is defined as the reduction in the incidence of a
disease among people who have received a vaccine
compared to the incidence in unvaccinated people.
> It is of importance in Randomized Control Trial.
Efficacy of Vaccine
Vaccine Efficacy =
(AR in Unvaccinated pop - AR in vaccinated pop) x 100
AR in unvaccinated population
AR (Attack Rate) = Total Cases of Disease x 100
Total Population
Example 1: In a clinical trial of new vaccine in the year 2001
following findings reported. 1600 infants were given three primary
doses diphtheria vaccine in one district, while 1200 infants were
not vaccinated with any diphtheria vaccine. Study continued for
three more years. By the end of study it was observed that 140
unvaccinated children and 18 vaccinated children developed
disease. Calculate efficacy.
Example 2: In a clinical trial of MR Vaccine in the year 2012 in India
following findings reported. 6000 infants were given MR vaccine in
one district, while 9000 infants were not vaccinated with any MR
containing vaccine. Study continued for five more years. By the end
of study it was observed that 120 unvaccinated children and 40
vaccinated children developed Rubela, whereas 160 unvaccinated
and 20 vaccinated children developed Measles. Calculate vaccine
efficacy for both.
Answers
1 82.85%
2 Measles = 81.46%
Rubella = 49.62%
Usage Rate for a vaccine (%)
= (Doses Administeredx100)/Doses issued
Wastage Rate for a vaccine (%)
= 100 – Usage Rate
= 100 – [(Doses Administeredx100)/Doses issued]
Definition :
Wastage rate(%) is the proportion of vaccine
(and other injection items) that is wasted due to
variety of reasons to that which was appropriately
used (i.e. number of infants vaccinated).
Wastage Factor
It is mathematical derivative used to account for the
correct amount needed for an immunization session,
taking into account the existing wastage rate.
i.e. If the wastage rate is 25%, it means if we carry vaccines in the
amount as per required by 100 children, there would be only 75
children, who are immunized, as 25% accounts to wastage.
> So, if we want to immunize 75 children  we have to carry 100
What if we want to immunize 100 children  ??
We have to carry (100 x 100)/75=133.33 =134
Wastage Multiplication Factor =
100/(100-Wastage rate)
In above example, it is 1.33.
Beneficiaries
Probable Number of Infants in area = Population x Birth rate
Probable Number of ANC =
(Population x Birth rate) + 10% wastage
Wastage is 10% of total birth, it is taken in count because of use
of vaccines for pregnant women, but those women do not give
birth (due to MTP, death of ANC or still-birth).
This data gives us annual benificiaries, so we have to divide
Infants and ANCs by 12 to get monthly benificiaries.
Example
Population of SC – 5000
Birth rate – 30/1000 population
Probable no. of Infants = ?
Probable no. of pregnancies = ?
Answer
Infants = 150
Pregnant women = 150 + 15 =165
(a) Calculate doses administered per month
 Doses administered per month=
Monthly target {infants or pregnant women} x number of
doses per beneficiary
(b) Calculate the monthly vaccine requirement with wastage
 Total vaccine doses used per month=
Doses administered per month x wastage multiplication
factor
Required Vaccines
• dT = (Monthly target of pregnant women X 1.5) +
(Monthly target of infants X 2)
> In case of pregnant women, some women have to take 2 dT
doses and some have to take only 1 dT booster, so average of the
two (i.e. 1.5) is taken.
• BCG = Monthly target of infants X 1
• Hep B = Monthly target of infants X 1
• OPV = Monthly target of infants X 5
• Pentavalent = Monthly target of infants X 3
• Rotavirus = Monthly target of infants X 3
• IPV = Monthly target of infants X 2
• MR = Monthly target of infants X 2
• DPT = Monthly target of infants X 2
• Vitamin A = Monthly target of infants X 9
Beneficiaries per month for each vaccine
(= Monthly beneficiary x total doses for full immunization)
Sr. No. Vaccine WMF
(Wastage rate%)
Doses per vial
1 Hep B 1.11 (10%) 10
2 BCG 2 (50%) 10
3 DPT 1.11 10
4 OPV 1.11 20
5 Rotavirus 1.11 2
6 IPV 1.11 25
7 Pentavalent 1.11 10
8 MR 1.33 (25%) 10
9 dT 1.11 10
10 Vitamin A 1.11 -
11 Syringes 1.11 -
• dT = {(Monthly target of pregnant women X 1.5) +
(Monthly target of infants X 2)} X 1.11
• BCG = Monthly target of infants X 1 X 2
• Hep B = Monthly target of infants X 1 X 1.11
• OPV = Monthly target of infants X 5 X 1.11
• Pentavalent = Monthly target of infants X 3 X 1.11
• Rotavirus = Monthly target of infants X 3 X 1.11
• IPV = Monthly target of infants X 2 X 1.11
• MR = Monthly target of infants X 2 X 1.33
• DPT = Monthly target of infants X 2 X 1.11
• Vitamin A = Monthly target of infants X 9 X 1.11
Doses required per month for each vaccine
(= Monthly beneficiary x total doses for full immunization x WMF)
• dT = {(Monthly target of pregnant women X 1.5)
+ (Monthly target of infants X 2)} X 1.11 /10
• BCG = Monthly target of infants X 1 X 2/10
• Hep B = Monthly target of infants X 1 X 1.11/10
• OPV = Monthly target of infants X 5 X 1.11/20
• Pentavalent = Monthly target of infants X 3 X
1.11/10
• Rotavirus = Monthly target of infants X 3 X 1.11/2
• IPV = Monthly target of infants X 2 X 1.11/25
• MR = Monthly target of infants X 2 X 1.33/10
• DPT = Monthly target of infants X 2 X 1.11/10
Vials required per month for each vaccine
{(= Monthly beneficiary x total doses for full immunization x WMF)/(Doses per vial)}
Vitamin A = {(no. of infants X 1) + (no. of infants X 2 X 8)} X 1.11 ml
= (No. of infants X 17) X 1.11 ml
Also, 1 bottle contains 100 ml of Vit A, so in case of calculation of
required bottles, requirement in ml is divided by 100.
For Vitamin A
Doses-
For Calculation of Syringes
0.1 ml ADS (Auto-Disabled Syringes) = Beneficiaries for BCG and fIPV x 1.11
0.5 ml ADS = (Beneficiaries for Hep B + Pentavalent + DPT + MR + dT) x 1.11
5 ml Reconstitution syringes = (BCG and Measles Vials) x 1.11
6 ml Syringes = 2 x Rotavirus Vials x 1.11
> 1st syringe is used for reconstitution and administration of 1st dose
> 2nd syringe is used to administer 2nd dose
Example
In PHC Vadal population is 26000. Birth rate was 2% so calculate
annual all vaccine requirement of PHC area.
Answer
Annual infants born = (26000 x 2)/100 = 520
Monthly infant target = 520/12 = 43.33 = 44
Annual ANC = 520 + 52 = 572
Monthly ANC target = 572/12 = 47.67 = 48
-> Vials Per Month :
dT = 18 Penta = 14.6 = 15
BCG = 9 Rota Virus = 73.26 = 74
Hep B = 5 MR = 11.7 = 12
OPV = 12.21 = 13 DPT = 9.7 = 8
->Syringes :
0.1 ml ADS = 132 x 1.11 = 146.52 = 147
0.5 ml ADS = 569
5 ml Reconstitution Syringes = (9 + 12) = 21
6 ml Syringes = 148 x 1.11 = 164.28 = 165
-> Vit-A = 830.28 ml = 9 bottles of 100 ml each

More Related Content

What's hot (20)

Rmnch+a
Rmnch+aRmnch+a
Rmnch+a
 
MR Campaign
MR Campaign MR Campaign
MR Campaign
 
A ideal case presention in psm
A ideal case presention in psmA ideal case presention in psm
A ideal case presention in psm
 
NTEP (National Tuberculosis Elimination Programme).pptx
NTEP (National Tuberculosis Elimination Programme).pptxNTEP (National Tuberculosis Elimination Programme).pptx
NTEP (National Tuberculosis Elimination Programme).pptx
 
JSY
JSYJSY
JSY
 
Rashtriya bal swasthya karyakram (rbsk)
Rashtriya bal swasthya karyakram (rbsk)Rashtriya bal swasthya karyakram (rbsk)
Rashtriya bal swasthya karyakram (rbsk)
 
EPI
EPIEPI
EPI
 
First referral unit
First referral unitFirst referral unit
First referral unit
 
MR Vaccination
MR VaccinationMR Vaccination
MR Vaccination
 
ICTC
ICTCICTC
ICTC
 
Wastage rate, Coverage rate , Dropout rate Calculation
Wastage rate, Coverage rate , Dropout rate CalculationWastage rate, Coverage rate , Dropout rate Calculation
Wastage rate, Coverage rate , Dropout rate Calculation
 
IMNCI
IMNCIIMNCI
IMNCI
 
IMNCI
IMNCIIMNCI
IMNCI
 
RNTCP
RNTCPRNTCP
RNTCP
 
JSSK
JSSKJSSK
JSSK
 
Community diagnosis
Community diagnosisCommunity diagnosis
Community diagnosis
 
Anaemia mukt bharat
Anaemia mukt bharatAnaemia mukt bharat
Anaemia mukt bharat
 
GATHER approach
GATHER  approach  GATHER  approach
GATHER approach
 
NTEP
NTEPNTEP
NTEP
 
Immunization
ImmunizationImmunization
Immunization
 

Similar to Vaccine Logistics

PRESENTATION ON IMMUNIZATION.pptx
PRESENTATION ON IMMUNIZATION.pptxPRESENTATION ON IMMUNIZATION.pptx
PRESENTATION ON IMMUNIZATION.pptxMuskan Thakur
 
Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...
Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...
Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...ILRI
 
Frequency Measures in pptx.pptx
Frequency Measures  in  pptx.pptxFrequency Measures  in  pptx.pptx
Frequency Measures in pptx.pptxandamlakdendir1
 
Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...
Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...
Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...Yotam Copelovitz
 
Expanded Program of Immunization (EPI) - DrFaten.ppt
Expanded Program of Immunization (EPI) - DrFaten.pptExpanded Program of Immunization (EPI) - DrFaten.ppt
Expanded Program of Immunization (EPI) - DrFaten.ppteunice332463
 
Chicken pox vaccine presentation jalandhar july 2017
Chicken pox vaccine presentation jalandhar july 2017Chicken pox vaccine presentation jalandhar july 2017
Chicken pox vaccine presentation jalandhar july 2017Gaurav Gupta
 
immunization dnm4 lesson 3.pptx
immunization                    dnm4 lesson 3.pptximmunization                    dnm4 lesson 3.pptx
immunization dnm4 lesson 3.pptxAnthonyMatu1
 
Quantifying Disease Occurrence
Quantifying Disease OccurrenceQuantifying Disease Occurrence
Quantifying Disease OccurrencePerez Eric
 
OS18 - 8.b.3 Modelling the Impact of Farming Practices upon Vaccine Effecti...
OS18 - 8.b.3   Modelling the Impact of Farming Practices upon Vaccine Effecti...OS18 - 8.b.3   Modelling the Impact of Farming Practices upon Vaccine Effecti...
OS18 - 8.b.3 Modelling the Impact of Farming Practices upon Vaccine Effecti...EuFMD
 
OM-85 Applicability in routine clinical practice - Professor Susanna Esposito
OM-85 Applicability in routine clinical practice - Professor Susanna EspositoOM-85 Applicability in routine clinical practice - Professor Susanna Esposito
OM-85 Applicability in routine clinical practice - Professor Susanna EspositoWAidid
 
Immunization schedule
Immunization scheduleImmunization schedule
Immunization scheduleanjalatchi
 
AAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptxAAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptxhelvi6
 
Understanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology studyUnderstanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology studykamolwantnok
 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfteddiyfentaw
 
Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...ILRI
 

Similar to Vaccine Logistics (20)

Vaccine pharmacovigilance _ rajiv ahlawat
Vaccine pharmacovigilance _ rajiv ahlawatVaccine pharmacovigilance _ rajiv ahlawat
Vaccine pharmacovigilance _ rajiv ahlawat
 
PRESENTATION ON IMMUNIZATION.pptx
PRESENTATION ON IMMUNIZATION.pptxPRESENTATION ON IMMUNIZATION.pptx
PRESENTATION ON IMMUNIZATION.pptx
 
Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...
Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...
Is my vaccination program working? Vaccine effectiveness: measuring vaccine p...
 
Frequency Measures in pptx.pptx
Frequency Measures  in  pptx.pptxFrequency Measures  in  pptx.pptx
Frequency Measures in pptx.pptx
 
Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...
Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...
Vaccine Issues and the World Small Animal Veterinary Association (WSAVA) Guid...
 
Lecture 07. Childhood Immunization
Lecture 07. Childhood ImmunizationLecture 07. Childhood Immunization
Lecture 07. Childhood Immunization
 
Expanded Program of Immunization (EPI) - DrFaten.ppt
Expanded Program of Immunization (EPI) - DrFaten.pptExpanded Program of Immunization (EPI) - DrFaten.ppt
Expanded Program of Immunization (EPI) - DrFaten.ppt
 
Chicken pox vaccine presentation jalandhar july 2017
Chicken pox vaccine presentation jalandhar july 2017Chicken pox vaccine presentation jalandhar july 2017
Chicken pox vaccine presentation jalandhar july 2017
 
immunization dnm4 lesson 3.pptx
immunization                    dnm4 lesson 3.pptximmunization                    dnm4 lesson 3.pptx
immunization dnm4 lesson 3.pptx
 
Quantifying Disease Occurrence
Quantifying Disease OccurrenceQuantifying Disease Occurrence
Quantifying Disease Occurrence
 
0406 marmorfws
0406 marmorfws0406 marmorfws
0406 marmorfws
 
OS18 - 8.b.3 Modelling the Impact of Farming Practices upon Vaccine Effecti...
OS18 - 8.b.3   Modelling the Impact of Farming Practices upon Vaccine Effecti...OS18 - 8.b.3   Modelling the Impact of Farming Practices upon Vaccine Effecti...
OS18 - 8.b.3 Modelling the Impact of Farming Practices upon Vaccine Effecti...
 
OM-85 Applicability in routine clinical practice - Professor Susanna Esposito
OM-85 Applicability in routine clinical practice - Professor Susanna EspositoOM-85 Applicability in routine clinical practice - Professor Susanna Esposito
OM-85 Applicability in routine clinical practice - Professor Susanna Esposito
 
Immunization schedule
Immunization scheduleImmunization schedule
Immunization schedule
 
AAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptxAAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptx
 
Understanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology studyUnderstanding the evidence in pharmacoepidemiology study
Understanding the evidence in pharmacoepidemiology study
 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdf
 
Flood preparedness saharsa
Flood preparedness saharsaFlood preparedness saharsa
Flood preparedness saharsa
 
Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...Mass vaccination, immunity and coverage: Modelling population protection agai...
Mass vaccination, immunity and coverage: Modelling population protection agai...
 
Epi for hsso
Epi for hssoEpi for hsso
Epi for hsso
 

Recently uploaded

Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jisc
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsSandeep D Chaudhary
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Pooja Bhuva
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxPooja Bhuva
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptxJoelynRubio1
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxakanksha16arora
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxmarlenawright1
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use CasesTechSoup
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Pooja Bhuva
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...Nguyen Thanh Tu Collection
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of PlayPooky Knightsmith
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfstareducators107
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsNbelano25
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Celine George
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 

Recently uploaded (20)

Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptx
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use Cases
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of Play
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdf
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf arts
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 

Vaccine Logistics

  • 2. Objectives :- 1. Vaccine Left Out 2. Vaccine Drop Out Rate 3. Efficacy of Vaccine 4. Vaccine and Materials (syringes) - Usage & Wastage rate - Wastage Factor - Calculation (Beneficiaries, Vaccines & Syringes)
  • 3. Vaccine Left Out A child or a woman, who has not taken any vaccine, even for which he/she is eligible, is known as Left Out Vaccine.
  • 4. Vaccine Dropout Rate Dropout is defined as a child or a woman who failed to return for subsequent doses of immunizations for which he/she is eligible. Drop out rate = Highest covered antigen - Lowest covered antigen x100 Highest covered antigen Over all drop out rate = Coverage with BCG - Coverage with measles x 100 Coverage with BCG Drop out rate for a single antigen(e.g. OPV) = Coverage with OPV1 - Coverage with OPV3 x 100 Coverage with OPV1
  • 5. Example 1: Calculate Pentavalent dropout rate and full immunization dropout rate for a PHC from the given data for the year 2015. Population of PHC was 30000. BCG coverage was 560. Pentavalent 1 & OPV 1 coverage was 580. Pentavalent 3 & OPV 3 coverage was 510. Measles coverage was 500. Example 2: Calculate Pentavalent, OPV dropout rate and full immunization dropout rate for a PHC from the given data for the year 2019. Population of PHC was 21000. BCG coverage was 650. Pentavalent 1 & OPV 1 coverage was 590 and 600. Pentavalent 3 & OPV 3 coverage was 560 and 590. Measles coverage was 550.
  • 6. Answers 1 Overall dropout = 10.71% Pentavalent dropout = 12.07% = OPV dropout 2 Overall dropout = 15.38% Pentavalent dropout = 5.1% OPV dropout = 1.67%
  • 7. Definition : It is defined as the reduction in the incidence of a disease among people who have received a vaccine compared to the incidence in unvaccinated people. > It is of importance in Randomized Control Trial. Efficacy of Vaccine Vaccine Efficacy = (AR in Unvaccinated pop - AR in vaccinated pop) x 100 AR in unvaccinated population AR (Attack Rate) = Total Cases of Disease x 100 Total Population
  • 8. Example 1: In a clinical trial of new vaccine in the year 2001 following findings reported. 1600 infants were given three primary doses diphtheria vaccine in one district, while 1200 infants were not vaccinated with any diphtheria vaccine. Study continued for three more years. By the end of study it was observed that 140 unvaccinated children and 18 vaccinated children developed disease. Calculate efficacy. Example 2: In a clinical trial of MR Vaccine in the year 2012 in India following findings reported. 6000 infants were given MR vaccine in one district, while 9000 infants were not vaccinated with any MR containing vaccine. Study continued for five more years. By the end of study it was observed that 120 unvaccinated children and 40 vaccinated children developed Rubela, whereas 160 unvaccinated and 20 vaccinated children developed Measles. Calculate vaccine efficacy for both.
  • 9. Answers 1 82.85% 2 Measles = 81.46% Rubella = 49.62%
  • 10. Usage Rate for a vaccine (%) = (Doses Administeredx100)/Doses issued Wastage Rate for a vaccine (%) = 100 – Usage Rate = 100 – [(Doses Administeredx100)/Doses issued] Definition : Wastage rate(%) is the proportion of vaccine (and other injection items) that is wasted due to variety of reasons to that which was appropriately used (i.e. number of infants vaccinated).
  • 11. Wastage Factor It is mathematical derivative used to account for the correct amount needed for an immunization session, taking into account the existing wastage rate. i.e. If the wastage rate is 25%, it means if we carry vaccines in the amount as per required by 100 children, there would be only 75 children, who are immunized, as 25% accounts to wastage. > So, if we want to immunize 75 children  we have to carry 100 What if we want to immunize 100 children  ?? We have to carry (100 x 100)/75=133.33 =134 Wastage Multiplication Factor = 100/(100-Wastage rate) In above example, it is 1.33.
  • 12. Beneficiaries Probable Number of Infants in area = Population x Birth rate Probable Number of ANC = (Population x Birth rate) + 10% wastage Wastage is 10% of total birth, it is taken in count because of use of vaccines for pregnant women, but those women do not give birth (due to MTP, death of ANC or still-birth). This data gives us annual benificiaries, so we have to divide Infants and ANCs by 12 to get monthly benificiaries. Example Population of SC – 5000 Birth rate – 30/1000 population Probable no. of Infants = ? Probable no. of pregnancies = ? Answer Infants = 150 Pregnant women = 150 + 15 =165
  • 13. (a) Calculate doses administered per month  Doses administered per month= Monthly target {infants or pregnant women} x number of doses per beneficiary (b) Calculate the monthly vaccine requirement with wastage  Total vaccine doses used per month= Doses administered per month x wastage multiplication factor Required Vaccines
  • 14. • dT = (Monthly target of pregnant women X 1.5) + (Monthly target of infants X 2) > In case of pregnant women, some women have to take 2 dT doses and some have to take only 1 dT booster, so average of the two (i.e. 1.5) is taken. • BCG = Monthly target of infants X 1 • Hep B = Monthly target of infants X 1 • OPV = Monthly target of infants X 5 • Pentavalent = Monthly target of infants X 3 • Rotavirus = Monthly target of infants X 3 • IPV = Monthly target of infants X 2 • MR = Monthly target of infants X 2 • DPT = Monthly target of infants X 2 • Vitamin A = Monthly target of infants X 9 Beneficiaries per month for each vaccine (= Monthly beneficiary x total doses for full immunization)
  • 15. Sr. No. Vaccine WMF (Wastage rate%) Doses per vial 1 Hep B 1.11 (10%) 10 2 BCG 2 (50%) 10 3 DPT 1.11 10 4 OPV 1.11 20 5 Rotavirus 1.11 2 6 IPV 1.11 25 7 Pentavalent 1.11 10 8 MR 1.33 (25%) 10 9 dT 1.11 10 10 Vitamin A 1.11 - 11 Syringes 1.11 -
  • 16. • dT = {(Monthly target of pregnant women X 1.5) + (Monthly target of infants X 2)} X 1.11 • BCG = Monthly target of infants X 1 X 2 • Hep B = Monthly target of infants X 1 X 1.11 • OPV = Monthly target of infants X 5 X 1.11 • Pentavalent = Monthly target of infants X 3 X 1.11 • Rotavirus = Monthly target of infants X 3 X 1.11 • IPV = Monthly target of infants X 2 X 1.11 • MR = Monthly target of infants X 2 X 1.33 • DPT = Monthly target of infants X 2 X 1.11 • Vitamin A = Monthly target of infants X 9 X 1.11 Doses required per month for each vaccine (= Monthly beneficiary x total doses for full immunization x WMF)
  • 17. • dT = {(Monthly target of pregnant women X 1.5) + (Monthly target of infants X 2)} X 1.11 /10 • BCG = Monthly target of infants X 1 X 2/10 • Hep B = Monthly target of infants X 1 X 1.11/10 • OPV = Monthly target of infants X 5 X 1.11/20 • Pentavalent = Monthly target of infants X 3 X 1.11/10 • Rotavirus = Monthly target of infants X 3 X 1.11/2 • IPV = Monthly target of infants X 2 X 1.11/25 • MR = Monthly target of infants X 2 X 1.33/10 • DPT = Monthly target of infants X 2 X 1.11/10 Vials required per month for each vaccine {(= Monthly beneficiary x total doses for full immunization x WMF)/(Doses per vial)}
  • 18. Vitamin A = {(no. of infants X 1) + (no. of infants X 2 X 8)} X 1.11 ml = (No. of infants X 17) X 1.11 ml Also, 1 bottle contains 100 ml of Vit A, so in case of calculation of required bottles, requirement in ml is divided by 100. For Vitamin A Doses-
  • 19. For Calculation of Syringes 0.1 ml ADS (Auto-Disabled Syringes) = Beneficiaries for BCG and fIPV x 1.11 0.5 ml ADS = (Beneficiaries for Hep B + Pentavalent + DPT + MR + dT) x 1.11 5 ml Reconstitution syringes = (BCG and Measles Vials) x 1.11 6 ml Syringes = 2 x Rotavirus Vials x 1.11 > 1st syringe is used for reconstitution and administration of 1st dose > 2nd syringe is used to administer 2nd dose Example In PHC Vadal population is 26000. Birth rate was 2% so calculate annual all vaccine requirement of PHC area.
  • 20. Answer Annual infants born = (26000 x 2)/100 = 520 Monthly infant target = 520/12 = 43.33 = 44 Annual ANC = 520 + 52 = 572 Monthly ANC target = 572/12 = 47.67 = 48 -> Vials Per Month : dT = 18 Penta = 14.6 = 15 BCG = 9 Rota Virus = 73.26 = 74 Hep B = 5 MR = 11.7 = 12 OPV = 12.21 = 13 DPT = 9.7 = 8 ->Syringes : 0.1 ml ADS = 132 x 1.11 = 146.52 = 147 0.5 ml ADS = 569 5 ml Reconstitution Syringes = (9 + 12) = 21 6 ml Syringes = 148 x 1.11 = 164.28 = 165 -> Vit-A = 830.28 ml = 9 bottles of 100 ml each